Last checked at 21 Feb 2023 13:41
SMITH & NEPHEW PLC
21 February 2023
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.
Smith & Nephew Global Share Plan 2020 (Performance Share Awards):
The following relates to individuals included in the below notification:
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Lapse of Performance Share Awards granted on 21 May 2020 under the Smith & Nephew Global Share Plan 2020 |
Date of Transaction | 2023 - 02 - 21 |
Place of Transaction | Lapse took place outside a trading venue |
Name of PDMR (Position) | Number of ordinary shares under award granted on 21/05/2020 (shown at maximum) | Number of ordinary shares lapsed under award (shown at maximum) | Number of ordinary shares outstanding under award (shown at maximum) |
Helen Barraclough (Group General Counsel & Company Secretary) | 10,982 | 10,982 | 0 |
Bradley Cannon (President Orthopaedics, Sports Medicine & ENT and Americas) | 29,624 | 29,624 | 0 |
Phil Cowdy (Chief Corporate Development & Corporate Affairs Officer) | 19,860 | 19,860 | 0 |
Myra Eskes (President APAC Region & Global Service) | 29,392 | 29,392 | 0 |
Simon Fraser (President Advanced Wound Management & Global Commercial Operations) | 25,628 | 25,628 | 0 |
Elga Lohler (Chief HR Officer) | 26,472 | 26,472 | 0 |
Vasant Padmanabhan (President Research & Development) | 25,638 | 25,638 | 0 |
Notes:
(i) Following completion of the performance measurement period, these awards lapsed in full on 21 February 2023.
(ii) Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 6 March 2023.
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0) 1923 477100